Pediatric Diabetes Management Market Size Worth USD 13.87 Billion by 2034 | CAGR: 9.5%

The pediatric diabetes management market size is expected to reach USD 13.87 Billion by 2034, according to a new study by Polaris Market Research. The report “Pediatric Diabetes Management Market Size, Share, Trends, & Industry Analysis Report By Technology (Connected Devices, Non-connected Devices), By Product, By End User, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pediatric diabetes management focuses on the diagnosis, treatment and monitoring of type 1 and type 2 diabetes in children and adolescents. This includes insulin therapies, digital glucose monitoring systems and integrated care approaches designed for pediatric populations.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/pediatric-diabetes-management-market/request-for-sample

Rising incidence of type 1 and type 2 diabetes in children, increasing childhood obesity and early onset of metabolic disorders are key factors driving market growth. Additionally, technological advancements in insulin delivery devices, continuous blood glucose monitoring devices (CGMs), and government-backed screening and education programs are supporting adoption across both developed and emerging markets.

Top of FormPediatric Diabetes Management Market Report Highlights

• In terms of product, the continuous glucose monitors (CGM) segment is expected to witness the fastest growth, due to high adoption in real-time glucose tracking for pediatric use.
• Based on technology, the non-connected segment held the dominant market share in 2024, due to affordability and usage in low-resource regions.
• Based on end user, the hospitals segment held the dominant market share in 2024, driven by high diagnosis rates and advanced pediatric care settings.
• North America accounted for largest pediatric diabetes management market share in 2024, driven by high disease burden, favorable reimbursement, and advanced clinical infrastructure.
• Asia Pacific is expected to grow significantly during the forecast period, fueled by growing diabetes incidence, expanding pediatric endocrinology services and improving healthcare accessibility.
• A few global key market players include Medtronic plc, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Ypsomed AG, Ascensia Diabetes Care, Glooko, Inc., AgaMatrix, Inc., EOFlow Co., Ltd., and Beta Bionics, Inc.

Polaris Market Research has segmented the market report on the basis of product, technology, end user, and region:

By Product Outlook (Revenue, USD Billion, 2020–2034)

• Blood Glucose Monitors (BGM)
• Continuous Glucose Monitors (CGM)
• Insulin Pumps
• Insulin Pens
• Insulin Syringes

By Technology Outlook (Revenue, USD Billion, 2020–2034)

• Connected Devices
• Non-connected Devices

By End User Outlook (Revenue, USD Billion, 2020–2034)

• Hospitals
  • General Hospitals
  • Children Hospitals
• Homecare
• Pediatric Clinics

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America